स्किज़ोफ्रेनिया
अंतिम अद्यतन 24 Mar 2026
मरीज की संपादकीय दिशानिर्देशों
- डाउनलोडडाउनलोड
- साझा करें
- Language
- चर्चा
- Ask Patient
- ऑडियो संस्करण
- Google पर पसंदीदा स्रोतों में जोड़ें
Schizophrenia is a disorder of the brain that affects a person's thoughts, perceptions, and behaviour. Affected individuals may have difficulty distinguishing between what is real and what is not (psychosis).
के लिए वीडियो चयन आनुवंशिक स्थितियाँवीडियो लाइब्रेरी
विवरण
Schizophrenia is a disorder of the brain that affects a person's thoughts, perceptions, and behaviour. Affected individuals may have difficulty distinguishing between what is real and what is not (psychosis).
Schizophrenia is typically diagnosed during late adolescence or early adulthood in men. The condition tends to be diagnosed slightly later in women. In a very small number of people, it can be diagnosed at a much younger age. The signs and symptoms of schizophrenia include hallucinations, which involve experiencing things that are not there. Hearing voices (auditory hallucination) is the most common type of hallucination that people with schizophrenia experience, but hallucinations may also involve sight, smell, or touch. Strongly held false beliefs (delusions) are also characteristic of schizophrenia. For example, affected individuals may be certain that they are a particular historical figure or that they are being plotted against or controlled by others.
Certain features of schizophrenia can make it difficult for affected individuals to function at school, at work, and in social settings. These features include odd and bizarre thinking and behaviour (disorganization), unpredictable or inappropriate emotional responses, jumbled speech that cannot be understood, and neglect of personal hygiene. Affected individuals often have difficulty expressing emotions through facial expressions or body movements (flat affect). Cognitive impairment, which can include problems with memory, concentration, and problem-solving, may also make it difficult for people with schizophrenia to live or work independently. Substance abuse and suicidal thoughts and actions are more common in people with schizophrenia than in the general population.
Abnormal movements, such as tremors, facial tics, rigidity, and unusually slow movement (bradykinesia), are often seen in people with schizophrenia. In many cases these abnormal movements are the side effects of the medicines that are prescribed to help control the disorder. However, some affected individuals exhibit movement abnormalities before starting medications, suggesting that the abnormal movements may be part of the disorder itself.
Some people with schizophrenia also have a mood disorder or severe mood symptoms, such as depression or periods of extreme excitement (mania). Mood disorders primarily affect a person's emotional state.
Inheritance patterns
The source lists the following possible inheritance patterns: Pattern unknown. More than one pattern can apply in different cases.
Other names
SCZD
Related patient information and medicines

Patient information leaflet
स्किज़ोफ्रेनिया
Symptoms include hearing, seeing, smelling or tasting things that are not real (hallucinations); false ideas (delusions); disordered thoughts and problems with feelings, behaviour and motivation. ...treatments and social supportTreatment includes medication, talking treatments and social support..

Patient information leaflet
एंटीसाइकोटिक दवाएं
Antipsychotics are medicines that are mainly used to treat schizophrenia or mania caused by bipolar disorder. Antipsychotics are a group of medicines that are mainly used to treat mental health illnesses such as schizophrenia Schizophrenia , or mania (where you feel high or elated) caused by bipolar disorder Bipolar disorder. As discussed above,.

Patient information leaflet
डायोजनीज सिंड्रोम
Risk factors Diogenes syndrome is often linked to one or more mental health conditions that include schizophrenia Schizophrenia , obsessive-compulsive disorder (OCD) Obsessive-compulsive disorder , depression Depression , dementia, Causes of memory loss and dementia addiction, especially to alcohol, and personality disorder. The diagnosis is made.

Patient information leaflet
मनोविकृति
Psychosis is a symptom but is not a diagnosis in itself. मनोविकृति can be caused by different mental health conditions, such as स्किज़ोफ्रेनिया or bipolar disorder, by physical illness or by other causes, such as bereavement or lack of sleep. What is psychosis. Psychosis means that yo... ServiceUpsellPlaceholder Causes of psychosis Psychosis can be.

Patient information leaflet
उदासीनता
उदाहरण के लिए: उदासीनता is a main symptom of schizophrenia Schizophrenia. Diagnosing apathy The diagnosis of apathy is made by a health professional based on: Your medical and medication history, including any neurological or psychosocial conditions you’ve had, to consider any underlying condition associated with apathy, or any mental health condition.

Patient information leaflet
हंटिंगटन की बीमारी
The disease was named after George Huntington who first described it in 1872. How common is Huntington's disease... Huntington's disease affects between 11 - 14 people per 100,000 in the UK, the rest of Europe and North America. Bipolar disorder Schizophrenia. Schizophrenia The personality changes related to Huntington's disease can be very.
अधिक पठन और संदर्भ
- स्किज़ोफ्रेनिया; MedlinePlus, National Library of Medicine.
- Barker V, Bois C, Johnstone EC, Owens DG, Whalley HC, McIntosh AM, Lawrie SM. Childhood adversity and cortical thickness and surface area in a population at familial high risk of schizophrenia. Psychol Med. 2016 Mar;46(4):891-6. doi: 10.1017/S0033291715002585. Epub 2015 Dec 14.
- Besterman AD. A genetics-guided approach to the clinical management of schizophrenia. Schizophr Res. 2024 May;267:462-469. doi: 10.1016/j.schres.2023.09.042. Epub 2023 Oct 7.
- Brah HS, Sran N, Sanghani S, Valmadrid L, Gandarilla I, Fakhouri S, Longmire E, Heskett KM, Kendall KM, Raznahan A, Baribeau D, Fan CC, Besterman AD. Clinical Genetic Testing in Schizophrenia: A Systematic Review and Meta-Analysis. Biol Psychiatry. 2026 Apr 1;99(7):541-549. doi: 10.1016/j.biopsych.2025.09.010. Epub 2025 Sep 30.
- Chafee MV, Averbeck BB. Unmasking Schizophrenia: Synaptic Pruning in Adolescence Reveals a Latent Physiological Vulnerability in Prefrontal Recurrent Networks. Biol Psychiatry. 2022 Sep 15;92(6):436-439. doi: 10.1016/j.biopsych.2022.06.023. No abstract available.
- Davis J, Eyre H, Jacka FN, Dodd S, Dean O, McEwen S, Debnath M, McGrath J, Maes M, Amminger P, McGorry PD, Pantelis C, Berk M. A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis. Neurosci Biobehav Rev. 2016 Jun;65:185-94. doi: 10.1016/j.neubiorev.2016.03.017. Epub 2016 Apr 9.
- Debost JP, Larsen JT, Munk-Olsen T, Mortensen PB, Meyer U, Petersen L. Joint Effects of Exposure to Prenatal Infection and Peripubertal Psychological Trauma in Schizophrenia. Schizophr Bull. 2017 Jan;43(1):171-179. doi: 10.1093/schbul/sbw083. Epub 2016 Jun 24.
- Gulsuner S, Walsh T, Watts AC, Lee MK, Thornton AM, Casadei S, Rippey C, Shahin H; Consortium on the Genetics of Schizophrenia (COGS); PAARTNERS Study Group; Nimgaonkar VL, Go RC, Savage RM, Swerdlow NR, Gur RE, Braff DL, King MC, McClellan JM. Spatial and temporal mapping of de novo mutations in schizophrenia to a fetal prefrontal cortical network. Cell. 2013 Aug 1;154(3):518-29. doi: 10.1016/j.cell.2013.06.049.
- Hany M, Rizvi A. Schizophrenia. 2024 Feb 23. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from http://www.ncbi.nlm.nih.gov/books/NBK539864/
- Jauhar S, Johnstone M, McKenna PJ. Schizophrenia. Lancet. 2022 Jan 29;399(10323):473-486. doi: 10.1016/S0140-6736(21)01730-X.
- Merikangas AK, Shelly M, Knighton A, Kotler N, Tanenbaum N, Almasy L. What genes are differentially expressed in individuals with schizophrenia? A systematic review. Mol Psychiatry. 2022 Mar;27(3):1373-1383. doi: 10.1038/s41380-021-01420-7. Epub 2022 Jan 28.
- Owen MJ, Legge SE, Rees E, Walters JTR, O'Donovan MC. Genomic findings in schizophrenia and their implications. Mol Psychiatry. 2023 Sep;28(9):3638-3647. doi: 10.1038/s41380-023-02293-8. Epub 2023 Oct 18.
- Palmer DS, Howrigan DP, Chapman SB, Adolfsson R, Bass N, Blackwood D, Boks MPM, Chen CY, Churchhouse C, Corvin AP, Craddock N, Curtis D, Di Florio A, Dickerson F, Freimer NB, Goes FS, Jia X, Jones I, Jones L, Jonsson L, Kahn RS, Landen M, Locke AE, McIntosh AM, McQuillin A, Morris DW, O'Donovan MC, Ophoff RA, Owen MJ, Pedersen NL, Posthuma D, Reif A, Risch N, Schaefer C, Scott L, Singh T, Smoller JW, Solomonson M, Clair DS, Stahl EA, Vreeker A, Walters JTR, Wang W, Watts NA, Yolken R, Zandi PP, Neale BM. Exome sequencing in bipolar disorder identifies AKAP11 as a risk gene shared with schizophrenia. Nat Genet. 2022 May;54(5):541-547. doi: 10.1038/s41588-022-01034-x. Epub 2022 Apr 11.
- Purcell SM, Moran JL, Fromer M, Ruderfer D, Solovieff N, Roussos P, O'Dushlaine C, Chambert K, Bergen SE, Kahler A, Duncan L, Stahl E, Genovese G, Fernandez E, Collins MO, Komiyama NH, Choudhary JS, Magnusson PK, Banks E, Shakir K, Garimella K, Fennell T, DePristo M, Grant SG, Haggarty SJ, Gabriel S, Scolnick EM, Lander ES, Hultman CM, Sullivan PF, McCarroll SA, Sklar P. A polygenic burden of rare disruptive mutations in schizophrenia. Nature. 2014 Feb 13;506(7487):185-90. doi: 10.1038/nature12975. Epub 2014 Jan 22.
- Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, Yenn Thoo H, Oliver D, Davies C, Morgan C, McGuire P, Murray RM, Fusar-Poli P. What causes psychosis? An umbrella review of risk and protective factors. World Psychiatry. 2018 Feb;17(1):49-66. doi: 10.1002/wps.20490.
- Robinson N, Bergen SE. Environmental Risk Factors for Schizophrenia and Bipolar Disorder and Their Relationship to Genetic Risk: Current Knowledge and Future Directions. Front Genet. 2021 Jun 28;12:686666. doi: 10.3389/fgene.2021.686666. eCollection 2021.
- Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014 Jul 24;511(7510):421-7. doi: 10.1038/nature13595. Epub 2014 Jul 22.
- Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Daly MJ, Carroll MC, Stevens B, McCarroll SA. Schizophrenia risk from complex variation of complement component 4. Nature. 2016 Feb 11;530(7589):177-83. doi: 10.1038/nature16549. Epub 2016 Jan 27.
- Singh T, Poterba T, Curtis D, Akil H, Al Eissa M, Barchas JD, Bass N, Bigdeli TB, Breen G, Bromet EJ, Buckley PF, Bunney WE, Bybjerg-Grauholm J, Byerley WF, Chapman SB, Chen WJ, Churchhouse C, Craddock N, Cusick CM, DeLisi L, Dodge S, Escamilla MA, Eskelinen S, Fanous AH, Faraone SV, Fiorentino A, Francioli L, Gabriel SB, Gage D, Gagliano Taliun SA, Ganna A, Genovese G, Glahn DC, Grove J, Hall MH, Hamalainen E, Heyne HO, Holi M, Hougaard DM, Howrigan DP, Huang H, Hwu HG, Kahn RS, Kang HM, Karczewski KJ, Kirov G, Knowles JA, Lee FS, Lehrer DS, Lescai F, Malaspina D, Marder SR, McCarroll SA, McIntosh AM, Medeiros H, Milani L, Morley CP, Morris DW, Mortensen PB, Myers RM, Nordentoft M, O'Brien NL, Olivares AM, Ongur D, Ouwehand WH, Palmer DS, Paunio T, Quested D, Rapaport MH, Rees E, Rollins B, Satterstrom FK, Schatzberg A, Scolnick E, Scott LJ, Sharp SI, Sklar P, Smoller JW, Sobell JL, Solomonson M, Stahl EA, Stevens CR, Suvisaari J, Tiao G, Watson SJ, Watts NA, Blackwood DH, Borglum AD, Cohen BM, Corvin AP, Esko T, Freimer NB, Glatt SJ, Hultman CM, McQuillin A, Palotie A, Pato CN, Pato MT, Pulver AE, St Clair D, Tsuang MT, Vawter MP, Walters JT, Werge TM, Ophoff RA, Sullivan PF, Owen MJ, Boehnke M, O'Donovan MC, Neale BM, Daly MJ. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022 Apr;604(7906):509-516. doi: 10.1038/s41586-022-04556-w. Epub 2022 Apr 8.
- Trubetskoy V, Pardinas AF, Qi T, Panagiotaropoulou G, Awasthi S, Bigdeli TB, Bryois J, Chen CY, Dennison CA, Hall LS, Lam M, Watanabe K, Frei O, Ge T, Harwood JC, Koopmans F, Magnusson S, Richards AL, Sidorenko J, Wu Y, Zeng J, Grove J, Kim M, Li Z, Voloudakis G, Zhang W, Adams M, Agartz I, Atkinson EG, Agerbo E, Al Eissa M, Albus M, Alexander M, Alizadeh BZ, Alptekin K, Als TD, Amin F, Arolt V, Arrojo M, Athanasiu L, Azevedo MH, Bacanu SA, Bass NJ, Begemann M, Belliveau RA, Bene J, Benyamin B, Bergen SE, Blasi G, Bobes J, Bonassi S, Braun A, Bressan RA, Bromet EJ, Bruggeman R, Buckley PF, Buckner RL, Bybjerg-Grauholm J, Cahn W, Cairns MJ, Calkins ME, Carr VJ, Castle D, Catts SV, Chambert KD, Chan RCK, Chaumette B, Cheng W, Cheung EFC, Chong SA, Cohen D, Consoli A, Cordeiro Q, Costas J, Curtis C, Davidson M, Davis KL, de Haan L, Degenhardt F, DeLisi LE, Demontis D, Dickerson F, Dikeos D, Dinan T, Djurovic S, Duan J, Ducci G, Dudbridge F, Eriksson JG, Fananas L, Faraone SV, Fiorentino A, Forstner A, Frank J, Freimer NB, Fromer M, Frustaci A, Gadelha A, Genovese G, Gershon ES, Giannitelli M, Giegling I, Giusti-Rodriguez P, Godard S, Goldstein JI, Gonzalez Penas J, Gonzalez-Pinto A, Gopal S, Gratten J, Green MF, Greenwood TA, Guillin O, Guloksuz S, Gur RE, Gur RC, Gutierrez B, Hahn E, Hakonarson H, Haroutunian V, Hartmann AM, Harvey C, Hayward C, Henskens FA, Herms S, Hoffmann P, Howrigan DP, Ikeda M, Iyegbe C, Joa I, Julia A, Kahler AK, Kam-Thong T, Kamatani Y, Karachanak-Yankova S, Kebir O, Keller MC, Kelly BJ, Khrunin A, Kim SW, Klovins J, Kondratiev N, Konte B, Kraft J, Kubo M, Kucinskas V, Kucinskiene ZA, Kusumawardhani A, Kuzelova-Ptackova H, Landi S, Lazzeroni LC, Lee PH, Legge SE, Lehrer DS, Lencer R, Lerer B, Li M, Lieberman J, Light GA, Limborska S, Liu CM, Lonnqvist J, Loughland CM, Lubinski J, Luykx JJ, Lynham A, Macek M Jr, Mackinnon A, Magnusson PKE, Maher BS, Maier W, Malaspina D, Mallet J, Marder SR, Marsal S, Martin AR, Martorell L, Mattheisen M, McCarley RW, McDonald C, McGrath JJ, Medeiros H, Meier S, Melegh B, Melle I, Mesholam-Gately RI, Metspalu A, Michie PT, Milani L, Milanova V, Mitjans M, Molden E, Molina E, Molto MD, Mondelli V, Moreno C, Morley CP, Muntane G, Murphy KC, Myin-Germeys I, Nenadic I, Nestadt G, Nikitina-Zake L, Noto C, Nuechterlein KH, O'Brien NL, O'Neill FA, Oh SY, Olincy A, Ota VK, Pantelis C, Papadimitriou GN, Parellada M, Paunio T, Pellegrino R, Periyasamy S, Perkins DO, Pfuhlmann B, Pietilainen O, Pimm J, Porteous D, Powell J, Quattrone D, Quested D, Radant AD, Rampino A, Rapaport MH, Rautanen A, Reichenberg A, Roe C, Roffman JL, Roth J, Rothermundt M, Rutten BPF, Saker-Delye S, Salomaa V, Sanjuan J, Santoro ML, Savitz A, Schall U, Scott RJ, Seidman LJ, Sharp SI, Shi J, Siever LJ, Sigurdsson E, Sim K, Skarabis N, Slominsky P, So HC, Sobell JL, Soderman E, Stain HJ, Steen NE, Steixner-Kumar AA, Stogmann E, Stone WS, Straub RE, Streit F, Strengman E, Stroup TS, Subramaniam M, Sugar CA, Suvisaari J, Svrakic DM, Swerdlow NR, Szatkiewicz JP, Ta TMT, Takahashi A, Terao C, Thibaut F, Toncheva D, Tooney PA, Torretta S, Tosato S, Tura GB, Turetsky BI, Ucok A, Vaaler A, van Amelsvoort T, van Winkel R, Veijola J, Waddington J, Walter H, Waterreus A, Webb BT, Weiser M, Williams NM, Witt SH, Wormley BK, Wu JQ, Xu Z, Yolken R, Zai CC, Zhou W, Zhu F, Zimprich F, Atbasoglu EC, Ayub M, Benner C, Bertolino A, Black DW, Bray NJ, Breen G, Buccola NG, Byerley WF, Chen WJ, Cloninger CR, Crespo-Facorro B, Donohoe G, Freedman R, Galletly C, Gandal MJ, Gennarelli M, Hougaard DM, Hwu HG, Jablensky AV, McCarroll SA, Moran JL, Mors O, Mortensen PB, Muller-Myhsok B, Neil AL, Nordentoft M, Pato MT, Petryshen TL, Pirinen M, Pulver AE, Schulze TG, Silverman JM, Smoller JW, Stahl EA, Tsuang DW, Vilella E, Wang SH, Xu S; Indonesia Schizophrenia Consortium; PsychENCODE; Psychosis Endophenotypes International Consortium; SynGO Consortium; Adolfsson R, Arango C, Baune BT, Belangero SI, Borglum AD, Braff D, Bramon E, Buxbaum JD, Campion D, Cervilla JA, Cichon S, Collier DA, Corvin A, Curtis D, Forti MD, Domenici E, Ehrenreich H, Escott-Price V, Esko T, Fanous AH, Gareeva A, Gawlik M, Gejman PV, Gill M, Glatt SJ, Golimbet V, Hong KS, Hultman CM, Hyman SE, Iwata N, Jonsson EG, Kahn RS, Kennedy JL, Khusnutdinova E, Kirov G, Knowles JA, Krebs MO, Laurent-Levinson C, Lee J, Lencz T, Levinson DF, Li QS, Liu J, Malhotra AK, Malhotra D, McIntosh A, McQuillin A, Menezes PR, Morgan VA, Morris DW, Mowry BJ, Murray RM, Nimgaonkar V, Nothen MM, Ophoff RA, Paciga SA, Palotie A, Pato CN, Qin S, Rietschel M, Riley BP, Rivera M, Rujescu D, Saka MC, Sanders AR, Schwab SG, Serretti A, Sham PC, Shi Y, St Clair D, Stefansson H, Stefansson K, Tsuang MT, van Os J, Vawter MP, Weinberger DR, Werge T, Wildenauer DB, Yu X, Yue W, Holmans PA, Pocklington AJ, Roussos P, Vassos E, Verhage M, Visscher PM, Yang J, Posthuma D, Andreassen OA, Kendler KS, Owen MJ, Wray NR, Daly MJ, Huang H, Neale BM, Sullivan PF, Ripke S, Walters JTR, O'Donovan MC; Schizophrenia Working Group of the Psychiatric Genomics Consortium. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022 Apr;604(7906):502-508. doi: 10.1038/s41586-022-04434-5. Epub 2022 Apr 8.
- Zhan N, Sham PC, So HC, Lui SSY. The genetic basis of onset age in schizophrenia: evidence and models. Front Genet. 2023 Jun 27;14:1163361. doi: 10.3389/fgene.2023.1163361. eCollection 2023.
हमारे में दूसरों के साथ अपने विचार या अनुभव साझा करें रोगी समुदायों.
पेशेंट न्यूज़लेटर के लिए साइन अप करें
आपकी साप्ताहिक खुराक स्पष्ट, विश्वसनीय स्वास्थ्य सलाह की - जो आपको सूचित, आत्मविश्वासी और नियंत्रण में महसूस करने में मदद करने के लिए लिखी गई है।.
सदस्यता लेने पर आप हमारी स्वीकार करते हैं गोपनीयता नीति. आप किसी भी समय सदस्यता समाप्त कर सकते हैं। हम कभी भी आपका डेटा नहीं बेचते।.

